• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements.

作者信息

Piñero-Crespo Gabriela, Kucharik Alison H, Chen Wei-Shen, Idiáquez Dietrich Werner, Doenges Josef, Zhang Yumeng, Sokol Lubomir, Glass Frank

机构信息

College of Medicine, University of South Florida Morsani, Tampa, Florida.

Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida.

出版信息

JAAD Case Rep. 2024 Nov 23;55:23-26. doi: 10.1016/j.jdcr.2024.09.032. eCollection 2025 Jan.

DOI:10.1016/j.jdcr.2024.09.032
PMID:39790106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11714132/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/158a3dcff16c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/eee40076a46d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/2b7e2a4ebb8c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/84fd84d545f8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/158a3dcff16c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/eee40076a46d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/2b7e2a4ebb8c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/84fd84d545f8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df18/11714132/158a3dcff16c/gr4.jpg

相似文献

1
Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements.皮肤表现作为伴有MYC和BCL2重排的弥漫性大B细胞淋巴瘤/高级别B细胞淋巴瘤的首发体征
JAAD Case Rep. 2024 Nov 23;55:23-26. doi: 10.1016/j.jdcr.2024.09.032. eCollection 2025 Jan.
2
[The incidence of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements in diffuse large B-cell lymphoma].[弥漫性大B细胞淋巴瘤中伴有MYC和BCL2及/或BCL6重排的高级别B细胞淋巴瘤的发病率]
Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):124-128. doi: 10.3760/cma.j.issn.0253-2727.2021.02.006.
3
Case report of high-grade B-cell lymphoma with and rearrangements presenting as compartment syndrome of the leg.伴有 和 重排的高级别B细胞淋巴瘤表现为腿部骨筋膜室综合征的病例报告。 （注：原文中“和”的具体内容缺失，这里是根据现有内容尽量完整翻译）
AME Case Rep. 2025 Mar 26;9:62. doi: 10.21037/acr-24-154. eCollection 2025.
4
Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas.原发性皮肤弥漫性大 B 细胞淋巴瘤中 MYC 和 BCL2 的双重表达或双重打击。
Mod Pathol. 2018 Aug;31(8):1332-1342. doi: 10.1038/s41379-018-0041-7. Epub 2018 Mar 26.
5
Inferior survival in high-grade B-cell lymphoma with and and/or rearrangements is not associated with gene rearrangements.伴有 和/或 重排的高级别 B 细胞淋巴瘤患者的生存情况较差，但与 基因重排无关。
Haematologica. 2018 Nov;103(11):1899-1907. doi: 10.3324/haematol.2018.190157. Epub 2018 Jun 14.
6
Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.双打击滤泡淋巴瘤的临床病理和基因组分析：与伴有 MYC 和 BCL2 及/或 BCL6 重排的高级别 B 细胞淋巴瘤的比较。
Mod Pathol. 2018 Feb;31(2):313-326. doi: 10.1038/modpathol.2017.134. Epub 2017 Oct 6.
7
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study).发病机制和影响因素：MYC 和 BCL2 重排的高级别 B 细胞淋巴瘤中的 MYC 重排（一项 LLMPP 研究）。
Blood. 2024 Aug 1;144(5):525-540. doi: 10.1182/blood.2024024251.
8
Clinical Significance of , C-, and Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.弥漫性大 B 细胞淋巴瘤中 、 、 和遗传异常、Epstein-Barr 病毒感染、CD5 蛋白表达、生发中心 B 细胞/非生发中心 B 细胞亚型、MYC/BCL2 蛋白共表达和 MYC/BCL2/BCL6 蛋白共表达的临床意义：120 例患者的临床与病理相关性研究。
Int J Med Sci. 2019 Apr 20;16(4):556-566. doi: 10.7150/ijms.27610. eCollection 2019.
9
Spinal lesion as the first manifestation of high-grade B-cell lymphoma, with and rearrangements.脊髓病变作为高级别B细胞淋巴瘤的首发表现，伴有 和 重排。 （你提供的原文中“with and rearrangements”部分信息不完整，请确认准确内容以便更精准翻译）
Int J Clin Exp Pathol. 2017 Aug 1;10(8):8858-8862. eCollection 2017.
10
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.MYC和BCL6同时重排及表达对初发弥漫性大B细胞淋巴瘤的预后影响
Oncotarget. 2016 Jan 19;7(3):2401-16. doi: 10.18632/oncotarget.6262.

本文引用的文献

1
A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma.巨大型皮肤弥漫性大 B 细胞淋巴瘤。
J Drugs Dermatol. 2023 Dec 1;22(12):1223-1224. doi: 10.36849/JDD.6936.
2
Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.皮肤 B 细胞淋巴瘤：2023 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Aug;98(8):1326-1332. doi: 10.1002/ajh.26968. Epub 2023 May 22.
3
Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
Myc 重排和 C-Myc/Bcl2 的同时高表达在弥漫性大 B 细胞淋巴瘤中预示不良预后。
Ann Diagn Pathol. 2023 Oct;66:152165. doi: 10.1016/j.anndiagpath.2023.152165. Epub 2023 May 24.
4
Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.《世界卫生组织血液淋巴系统肿瘤分类第5版——更新后的分类与新概念》中的大B细胞淋巴瘤
Cancers (Basel). 2023 Apr 13;15(8):2285. doi: 10.3390/cancers15082285.
5
Epidemiology of Non-Hodgkin's Lymphoma.非霍奇金淋巴瘤的流行病学。
Med Sci (Basel). 2021 Jan 30;9(1):5. doi: 10.3390/medsci9010005.
6
Diffuse large B-Cell lymphoma associated with paraneoplastic Guillain-Barré syndrome: A diagnostic and therapeutic challenge.弥漫性大B细胞淋巴瘤合并副肿瘤性吉兰-巴雷综合征：诊断与治疗挑战
Hematol Oncol Stem Cell Ther. 2020 May 20. doi: 10.1016/j.hemonc.2020.05.008.
7
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens.双打击弥漫性大B细胞淋巴瘤中CD5表达的预后分析及剂量调整EPOCH联合利妥昔单抗/R-CHOP方案治疗患者的疗效比较
Blood Lymphat Cancer. 2019 Aug 19;9:33-43. doi: 10.2147/BLCTT.S216292. eCollection 2019.
8
Diffuse large B-cell lymphoma associated with skin, muscle and cranial nerve involvement.与皮肤、肌肉和颅神经受累相关的弥漫性大B细胞淋巴瘤。
Eur J Dermatol. 2000 Jun;10(4):306-8.